In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
- 14 April 2020
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 178, 104794
- https://doi.org/10.1016/j.antiviral.2020.104794
Abstract
No abstract availableKeywords
Funding Information
- National Research Council of Science and Technology (2018ZX10301402)
- National Natural Science Foundation of China (81761148025)
- Guangzhou Science and Technology (201704020093)
- Pearl
- Russian Foundation for Basic Research (17-54-80078)
- National Research Foundation
This publication has 42 references indexed in Scilit:
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonucleaseNature Biotechnology, 2013
- Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivoGynecologic Oncology, 2012
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- Oncogenic activities of human papillomavirusesVirus Research, 2009
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Papillomavirus and treatmentAntiviral Research, 2006
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003
- Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma CellsJournal of Virology, 2003
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990